Invesque Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Invesque heeft een totaal eigen vermogen van $115.4M en een totale schuld van $471.9M, wat de schuld-eigenvermogensverhouding op 408.8% brengt. De totale activa en totale passiva bedragen respectievelijk $711.1M en $595.7M. De EBIT Invesque is $35.7M waardoor de rentedekking 0.6 is. Het heeft contanten en kortetermijnbeleggingen van $13.9M.

Belangrijke informatie

408.8%

Verhouding schuld/eigen vermogen

US$471.87m

Schuld

Rente dekkingsratio	0.6x
Contant	US$13.86m
Aandelen	US$115.43m
Totaal verplichtingen	US$595.67m
Totaal activa	US$711.10m

Recente financiële gezondheidsupdates

Recent updates

Calculating The Fair Value Of Invesque Inc. (TSE:IVQ)

Oct 30

Here's Why Invesque (TSE:IVQ) Is Weighed Down By Its Debt Load

Aug 17

These 4 Measures Indicate That Invesque (TSE:IVQ) Is Using Debt In A Risky Way

May 03

Invesque Inc.'s (TSE:IVQ) Share Price Boosted 55% But Its Business Prospects Need A Lift Too

Feb 23

Invesque Inc.'s (TSE:IVQ) Shares Bounce 55% But Its Business Still Trails The Industry

Feb 23

It's Down 25% But Invesque Inc. (TSE:IVQ) Could Be Riskier Than It Looks

Aug 29

Is Invesque (TSE:IVQ) Using Too Much Debt?

Jul 18

Does Invesque (TSE:IVQ) Have A Healthy Balance Sheet?

Mar 17

Should You Investigate Invesque Inc. (TSE:IVQ) At CA$2.60?

Jan 01

Estimating The Intrinsic Value Of Invesque Inc. (TSE:IVQ)

Dec 06

Here's Why Invesque (TSE:IVQ) Is Weighed Down By Its Debt Load

Aug 05

An Intrinsic Calculation For Invesque Inc. (TSE:IVQ) Suggests It's 48% Undervalued

Mar 09

What Kind Of Shareholders Hold The Majority In Invesque Inc.'s (TSE:IVQ) Shares?

Feb 10

Invesque (TSE:IVQ) Share Prices Have Dropped 73% In The Last Year

Jan 06

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $421.9M ) van IVQ } dekken niet de korte termijn passiva ( $446.2M ).

Langlopende schulden: De kortetermijnactiva IVQ ( $421.9M ) overtreffen de langetermijnschulden ( $149.5M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 396.8% ) IVQ wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van IVQ is de afgelopen 5 jaar gestegen van 208.9% naar 408.8%.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: Terwijl het verlieslatende IVQ voldoende cash runway heeft voor meer dan 3 jaar, als het zijn huidige positieve vrije kasstroom-niveau behoudt.

Voorspelling contante baan: IVQ is verlieslatend, maar heeft voldoende kasmiddelen voor meer dan 3 jaar, zelfs bij een positieve vrije kasstroom die met 22.7 % per jaar krimpt.

Invesque Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Here's Why Invesque (TSE:IVQ) Is Weighed Down By Its Debt Load

These 4 Measures Indicate That Invesque (TSE:IVQ) Is Using Debt In A Risky Way

Is Invesque (TSE:IVQ) Using Too Much Debt?

Does Invesque (TSE:IVQ) Have A Healthy Balance Sheet?

Here's Why Invesque (TSE:IVQ) Is Weighed Down By Its Debt Load

Recent updates

Third quarter 2024 earnings released: US$0.13 loss per share (vs US$0.013 profit in 3Q 2023)

Invesque Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2024

Now 22% undervalued after recent price drop

Calculating The Fair Value Of Invesque Inc. (TSE:IVQ)

Now 27% overvalued

Insufficient new directors

Here's Why Invesque (TSE:IVQ) Is Weighed Down By Its Debt Load

Second quarter 2024 earnings released: US$0.27 loss per share (vs US$0.81 loss in 2Q 2023)

An undisclosed buyer acquired skilled nursing facility in Wisconsin from Invesque Inc. (TSX:IVQ) for $5060.

New major risk - Market cap size

First quarter 2024 earnings released: US$0.10 loss per share (vs US$0.19 loss in 1Q 2023)

These 4 Measures Indicate That Invesque (TSE:IVQ) Is Using Debt In A Risky Way

Invesque Inc. Announces Chief Executive Officer Changes, Effective May 10, 2024

Invesque Inc., Annual General Meeting, Jun 20, 2024

Now 21% undervalued

Invesque Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended December 31, 2023

Now 22% undervalued

Invesque Inc.'s (TSE:IVQ) Share Price Boosted 55% But Its Business Prospects Need A Lift Too

Invesque Inc.'s (TSE:IVQ) Shares Bounce 55% But Its Business Still Trails The Industry

New major risk - Share price stability

Third quarter 2023 earnings released: EPS: US$0.01 (vs US$0.22 loss in 3Q 2022)

Now 22% undervalued after recent price drop

It's Down 25% But Invesque Inc. (TSE:IVQ) Could Be Riskier Than It Looks

Second quarter 2023 earnings released: US$0.82 loss per share (vs US$0.16 loss in 2Q 2022)

Invesque Inc. to Report Q2, 2023 Results on Aug 14, 2023

Is Invesque (TSE:IVQ) Using Too Much Debt?

Invesque Inc. Announces Chief Financial Officer Changes

First quarter 2023 earnings released: US$0.19 loss per share (vs US$0.10 profit in 1Q 2022)

Full year 2022 earnings released: US$0.74 loss per share (vs US$0.22 loss in FY 2021)

Third quarter 2022 earnings released: US$0.24 loss per share (vs US$0.09 loss in 3Q 2021)

Invesque Inc. to Report Q3, 2022 Results on Nov 08, 2022

Hillcrest Health Service System, Inc. acquired Two Skilled Nursing Facilities Comprised of 148 Beds in Nebraska from Invesque Inc. (TSX:IVQ) for $24.9 million.

Second quarter 2022 earnings released: US$0.17 loss per share (vs US$0.062 loss in 2Q 2021)

Centurion Asset Management Inc. and Appelt Properties Inc. acquired Healthcare Real Estate Portfolio Located in Ontario and Alberta from Invesque Inc. (TSX:IVQ) for CAD 94.6 million.

Invesque Inc. to Report Q2, 2022 Results on Aug 09, 2022

First quarter 2022 earnings released: EPS: US$0.06 (vs US$0.032 in 1Q 2021)

Invesque Inc. to Report Q1, 2022 Results on May 11, 2022

Invesque Inc., Annual General Meeting, Jun 22, 2022

Chairman & CEO exercised options to buy CA$88k worth of stock.

Does Invesque (TSE:IVQ) Have A Healthy Balance Sheet?

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Invesque Inc. to Report Q4, 2021 Results on Mar 09, 2022

Chairman & CEO exercised options to buy CA$143k worth of stock.

Should You Investigate Invesque Inc. (TSE:IVQ) At CA$2.60?

Estimating The Intrinsic Value Of Invesque Inc. (TSE:IVQ)

Third quarter 2021 earnings released: US$0.09 loss per share (vs US$1.09 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.06 loss per share (vs US$0.54 loss in 2Q 2020)

Here's Why Invesque (TSE:IVQ) Is Weighed Down By Its Debt Load

Independent Director has left the company

Lead Independent Director has left the company

First quarter 2021 earnings released: EPS US$0.03 (vs US$1.04 loss in 1Q 2020)

Chairman & CEO exercised options to buy CA$164k worth of stock.

Invesque Inc., Annual General Meeting, May 18, 2021

Revenue beats expectations

Full year 2020 earnings released: US$3.30 loss per share (vs US$0.099 loss in FY 2019)

Invesque Inc. (TSX:IVQ) acquired 32-unit memory care facility located in Rogers, AR.

An Intrinsic Calculation For Invesque Inc. (TSE:IVQ) Suggests It's 48% Undervalued

New 90-day high: CA$3.20

What Kind Of Shareholders Hold The Majority In Invesque Inc.'s (TSE:IVQ) Shares?

New 90-day high: CA$3.10

Invesque Inc. to Report Q4, 2020 Results on Mar 10, 2021

Chairman exercised options to buy CA$109k worth of stock.

Invesque (TSE:IVQ) Share Prices Have Dropped 73% In The Last Year

Third quarter 2020 earnings released: US$1.09 loss per share

New 90-day low: CA$2.25

Invesque Inc. to Report Q3, 2020 Results on Nov 11, 2020

New 90-day low: CA$2.50

New 90-day low - CA$2.61

Earnings released

Invesque Inc. to Report Q2, 2020 Results on Aug 12, 2020